Korea When you establish an ecosystem where researchers can freely generate and test ideas, they can rapidly address critical real-world challenges At his lab in KAIST’s Department of Chemical and Biomolecular Engineering, Distinguished Professor Sang Yup Lee is pioneering microbial cell factory technologies to replace fossil-fuel-based manufacturing with sustainable biomanufacturing.…
Germany Prof Dr Markus M. Lerch, Physician-in-Chief and CEO of Munich University Hospital, oversees more than 2,000 concurrent clinical trials and a EUR 2.2 billion campus rebuild now underway in Bavaria. Dr Lerch explains why Germany’s 1,800-hospital system needs consolidation, how the new Munich Medicine Alliance will streamline trial access for…
Germany Dr Holm Graessner has spent more than 20 years building the infrastructure that rare disease patients in Europe often lack entirely: diagnostic pathways, European reference networks, and academic drug development for conditions too rare to interest any pharmaceutical company. As Managing Director of the Rare Disease Centre at Tübingen University…
Europe The goal is not only to generate scientific breakthroughs, but to ensure that these breakthroughs reach patients faster and more reliably Professor Gerd Geisslinger serves as Chair of Clinical Pharmacology at Goethe University Hospital and as Executive Director of the Fraunhofer Institute for Translational Medicine and Pharmacology (ITMP), which is…
Taiwan Jaw-Jou Kang, Professor at NYCU, former head of Taiwan’s Food and Drug Administration and current chair of the Taiwan Society of Regulatory Affairs for Medicinal Products discusses the nation’s regulatory transformation, challenges in talent retention, advances in regenerative medicine frameworks, and Taiwan’s positioning within the global biopharmaceutical ecosystem whilst navigating…
Lebanon Dr Ali Taher, MD, PhD, FRCP, has spent more than three decades shaping the understanding and treatment of thalassemia. As Associate VP for Academic Centers at the American University of Beirut (AUB) and Director of the Naef K. Basile Cancer Institute, he has integrated high-level research with clinical excellence. Trained…
Hong Kong Professor Chak-sing Lau, BBS, JP, is Vice-President & Pro-Vice-Chancellor (Health) and Dean of Medicine at The University of Hong Kong (HKU). He leads HKU’s Li Ka Shing Faculty of Medicine (HKUMed), one of Asia’s highest-ranked medical schools. Professor Lau discusses the faculty’s evolution into a multidisciplinary health sciences hub, Hong…
USA Priya Kishnani, Director of the Division of Medical Genetics at Duke University School of Medicine, discusses how multidisciplinary care, global collaboration, and rapidly advancing therapeutic technologies are reshaping the rare disease landscape. Drawing on decades of experience across diagnosis, natural history research, and the development of transformative treatments, she outlines…
Taiwan In 2024, Taipei Medical University reached a defining milestone. President Mai-Szu Wu oversaw a full digital transformation linking seven affiliated medical institutions and more than 3,000 beds into a unified data platform, creating a foundation for large-scale research, AI applications, and faster clinical-trial operations. This momentum has now extended nationwide…
France This conversation with Bruno Dubois offers a clear, experience-driven perspective on how Alzheimer’s disease is being redefined, from diagnosis and biomarkers to prevention and early intervention. Drawing on decades at the forefront of neurology, he challenges simplified biological definitions, explains why risk must be stratified with rigour, and outlines a…
Taiwan Professor Pan Chyr Yang is a clinician-scientist with an MD and PhD in pulmonary medicine, holding joint appointments at Academia Sinica and former university leadership roles in National Taiwan University. Recognised for pioneering non-smoker lung cancer screening methodologies in Asia, he has established national surveillance programmes now adopted across the region.…
Switzerland Dr. Olivier Michielin serves as Head of Oncology at Geneva University Hospital (HUG) and Head of the Division of Precision Oncology, whilst maintaining his professorship at the University of Geneva as well as the École Polytechnique Fédérale de Lausanne (EPFL). A co-director of the Swiss Cancer Centre Leman, Dr. Michelin…
See our Cookie Privacy Policy Here